Governance Celltrion, Inc.

A068270

KR7068270008

Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 10/04/2026			5-day change	1st Jan Change
199,700.00 ^KRW	-0.89%		+2.25%	+10.33%

04-08	Nomura Adjusts Celltrion's Price Target to KRW270,000 From KRW240,000, Keeps at Buy	MT
04-03	South Korean shares fall for second week on Middle East worries	RE

Executive Committee: Celltrion, Inc.

Manager

Positions heldSince

Jin-Seok Seo

42 year

Chief Executive Officer

25/03/2021

Kyung-Ha Shin

53 year

General Counsel

Hyun-Joo Yang

55 year

Human Resources Officer

Gi-Seong Kw

57 year

Chief Tech/Sci/R&D Officer

Jeong-Su Seo

67 year

Human Resources Officer

Wu-Sung Ki

65 year

Chief Executive Officer

19/03/2015

Hyeok-Jae Lee

50 year

President

12/02/2026

Ho-Seop Lee

51 year

Director of Finance/CFO

Byeong-Seo Choi

57 year

Sales & Marketing

Composition of the Board of Directors: Celltrion, Inc.

Director

CommitteesSince

Jung-Jin Seo

68 year

Nominating Committee

Geun-Young Kim

66 year

Audit Committee
Compensation Committee
Nominating Committee

Dae-Hyeon Yoo

67 year

Audit Committee
Compensation Committee
Nominating Committee Chair

Soon-Woo Lee

75 year

Audit Committee
Nominating Committee
Compensation Committee Chair

Jae-Sik Lee

68 year

Compensation Committee
Nominating Committee
Audit Committee Chair

Joong-Jae Lee

63 year

Audit Committee	27/12/2023
Compensation Committee	27/12/2023
Nominating Committee	27/12/2023

Young-Hye Ko

71 year

Audit Committee	24/03/2022
Compensation Committee	24/03/2022
Nominating Committee	24/03/2022

Hyung-Ki Kim

60 year

Director/Board Member

31/03/2005

Wu-Sung Ki

65 year

Director/Board Member

23/04/2007

Jin-Seok Seo

42 year

Director/Board Member

25/03/2021

Latest Appointments: Celltrion, Inc.

07/03/23

Celltrion Group Creator Expected to Resume Leadership Role

More news

Former Officers and Directors: Celltrion, Inc.

Insider

Positions held

SinceUntil

Won-Seok Kim

Director/Board Member	-	31/03/2022
Independent Dir/Board Member	-	31/03/2022

Jong-Seok Lee

Director/Board Member	07/12/2014	-
Independent Dir/Board Member	07/12/2014	-

Byung-Hoon Jeon

Director/Board Member	26/03/2014	-
Independent Dir/Board Member	26/03/2014	-

Hong-Hee Cho

Director/Board Member	21/03/2013	-
Independent Dir/Board Member	21/03/2013	-

Zheru Zhang

Chief Tech/Sci/R&D Officer

29/02/2008

30/09/2012

Jin-Kyu Wang

Corporate Officer/Principal

01/06/2011

29/04/2012

Brian Byeoung Kim

Corporate Officer/Principal

31/05/2011

29/04/2012

Daniel P. Slone

Corporate Officer/Principal

31/05/2011

John S. Kim

Corporate Officer/Principal

01/06/2011

Hans-Peter Hasler

Director/Board Member	31/05/2011	-
Independent Dir/Board Member	31/05/2011	-

Gyun-Seok Cho

Director/Board Member	19/03/2009	-
Independent Dir/Board Member	19/03/2009	-

Gyung-Ho Lee

Director/Board Member

16/07/2008

Dong-Il Kim

Director/Board Member	16/07/2008	-
Independent Dir/Board Member	16/07/2008	-

Joseph Lee

Director/Board Member	16/07/2008	-
Independent Dir/Board Member	16/07/2008	-

James Panek

Chief Executive Officer	31/12/2001	31/12/2005
Chairman	31/12/2001	31/12/2005

Sung-Do Park

Corporate Officer/Principal

01/06/2011

Seung-Seo Hong

Chief Tech/Sci/R&D Officer

31/05/2011

Sung-Han Lee

Compliance Officer	-	-
General Counsel	-	-

Elizabeth Pollitt

Corporate Officer/Principal

Alex Kudrin

Corporate Officer/Principal

Hee-Choon Yang

Corporate Officer/Principal

31/05/2011

Jae Chung

Founder	-	-
Corporate Officer/Principal	-	-

Yong-Jik Kim

Corporate Officer/Principal

31/05/2011

Min-Young Soh

Corporate Officer/Principal

31/05/2011

Serge S. Laveault

Corporate Officer/Principal

Dong-Gyu Ji

Corporate Officer/Principal

Sang-Joon Lee

Corporate Officer/Principal

Gail M. Ward

Corporate Officer/Principal

Shin-Jae Jang

Corporate Officer/Principal

Myung-Geun Oh

Chief Operating Officer	-	-
Corporate Officer/Principal	-	-

Yun-Sook Jang

Corporate Officer/Principal

01/06/2011

Kwang-Ho Kim

Corporate Officer/Principal

31/05/2011

Ho-Eun Yoo

Corporate Officer/Principal

01/06/2011

Ik-Sung Ahn

Corporate Officer/Principal

01/06/2011

Jae-Hyeon Kim

Corporate Officer/Principal

01/06/2011

Geun-Kyung Lee

Corporate Officer/Principal

31/05/2011

Young-Seon Kwon

Corporate Officer/Principal

01/06/2011

Bok-Jong Hyun

Corporate Officer/Principal

01/06/2011

Je-Roo Jang

Corporate Officer/Principal

01/06/2011

Seung-Heon Nam

Corporate Officer/Principal

31/05/2011

Young-Deok Gwon

Corporate Officer/Principal

Gang-Heui Cho

Corporate Officer/Principal

In-Kyu Kim

Corporate Officer/Principal

31/05/2011

Hong-Seok Cho

Corporate Officer/Principal

01/06/2011

Age distribution of managers

Parity Men Women

Male	18
Female	2

Of which Executive Committee

Male	7
Female	2

Of which Directors

Male	10
Female	0

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Celltrion Inc is a Korea-based company mainly engaged in the production and sale of bio pharmaceuticals. The Company operates its business through two segments. The Bio Pharmaceutical segment produces and sells protein therapeutics such as anticancer drugs. In addition, this Segment develops monoclonal antibodies(mABs) that are used to treat chronic autoimmune diseases such as arthritis and severe diseases such as breast and colon cancer. The Chemical Pharmaceutical segment is mainly engaged in the manufacture and sale of chemical drugs. In addition, the Segment sells bio drugs, and provides services such as data analysis. The Company's main products include liver and bowel medicines and other generics. The main products sold by the Company include autoimmune disease treatment agents, anti-malignant tumor drugs and other products. The Company sells its products in domestic and overseas markets such as Europe and the United States.

Employees

2,680

Sector

Biotechnology & Medical Research

More about the company